Carbapenem-based Antibiotics Market Growth, Forecast and Application to 2029

Fact.MR’s Report on Global Carbapenem-Based Antibiotics Market

In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global carbapenem-based antibiotics market considering 2014-2018 as the historic year and 2019–2029 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 – 2021.

Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of patent for ertapenem is expected to offer new avenues for market growth in regulated as well as non-regulated carbapenem-based antibiotics market where its adoption & availability are comparatively limited. On the back of these factors, the global carbapenem-based antibiotics market is estimated to reach a valuation of US$1.8 Bn by 2029.

The research study on carbapenem-based antibiotics market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends which have shaped the landscape of carbapenem-based antibiotics over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029.

Market statistics have been presented on the basis of product type (Meropenem, imipenem, ertapenem, tebipenem, doripenem, panipenem, etc.), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, others), sales channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions.

For a detailed industry outlook, Get the Report Sample at: https://www.factmr.com/connectus/sample?flag=S&rep_id=4425

The carbapenem-based antibiotics market report addresses the below-mentioned queries:

  • Why are vendors shifting away from traditional methods of manufacturing carbapenem-based antibiotics market?
  • How does the global carbapenem-based antibiotics market looks like in the next five years?
  • Which end use industry is expected to surpass segment by the end of 2029?
  • What innovative products are being introduced by the players in the global carbapenem-based antibiotics market?
  • Which regions are showing the fastest market growth?

On the basis of product type, the carbapenem-based antibiotics market study consists of

  • Meropenem
  • Ertapenem
  • Imipenem
  • Doripenem
  • Panipenem
  • Tebipenem

On the basis of indication, the carbapenem-based antibiotics market study incorporates:

  • Intra-abdominal Infections
  • Urinary Tract Infections
  • Pneumonia
  • Bacterial Meningitis
  • Skin and Skin Structure Infections
  • Acute Pelvic Infections
  • Prophylaxis of Surgical Site Infection
  • Respiratory Tract Infections
  • Gynaecologic Infections
  • Endocarditis

Crucial insights in the carbapenem-based antibiotics market research:

  • Underlying macro- and microeconomic factors impacting the growth of the carbapenem-based antibiotics market.
  • Basic overview of the carbapenem-based antibiotics market, including market definition, classification, and applications.
  • Scrutinization of each carbapenem-based antibiotics market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of carbapenem-based antibiotics market across various industries.
  • Important regions and countries offering lucrative opportunities to carbapenem-based antibiotics market stakeholders.

For Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4425

Reasons to choose Fact.MR:

  • Exhaustive research regarding the market to offer A to Z information.
  • Digital technologies to provide innovative business solutions to the clients.
  • 24/7 availability of services.
  • Interaction with suppliers, vendors, and service providers for precise market landscape.
  • Reports tailored as per the requirements of the clients.

Comments are closed